Suppr超能文献

评估Charlson合并症指数和实验室参数作为新冠病毒19患者早期死亡率的独立预测指标

Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients.

作者信息

Cavuşoğlu Türker Betül, Türker Fatih, Ahbab Süleyman, Hoca Emre, Urvasızoğlu Ayşe Oznur, Cetin Seher Irem, Ataoğlu Hayriye Esra

机构信息

University of Health Sciences, Taksim Health Training and Research Hospital, Internal Medicine Clinic, İstanbul, Turkey.

University of Health Sciences, Haseki Health Training and Research Hospital, Internal Medicine Clinic, İstanbul, Turkey.

出版信息

Int J Gen Med. 2022 Jul 27;15:6301-6307. doi: 10.2147/IJGM.S374246. eCollection 2022.

Abstract

PURPOSE

Various parameters have been proposed to predict the outcome of patients with coronavirus disease. The aim of this study was to evaluate the utility of the age-adjusted CCI score and biochemical parameters for predicting outcomes for COVID-19 patients on admission.

PATIENTS AND METHODS

A total of 511 patients were included in the study. Only swab or serological tests positive patients were included. The clinical characteristics of the patients were compared between survival and non-survival COVID-19 inpatients. Hemoglobin, platelet, sedimentation, creatinine, AST, ALT, LDH, CK, albumin, ferritin, lymphocyte, neutrophil, CRP (1-5;5-10;10-20 × upper limit), procalcitonin (5-10;10-20; > 20 × upper limit), D Dimer (> 2 × upper limit), age, gender, chronic diseases and CCI scores were compared between the two groups.

RESULTS

68 patients died and 443 patients survived. Mean age was 74.3±7.3 years in survival group and 76.7±8.0 in nonsurvival group. Age, male sex, ischemic heart disease (CHD), chronic kidney disease and active malignancy was statistically higher in non-survivor group. The biochemical parameters was compared in survival and nonsurvival group. CCI score, AST, LDH, CK, Ferritin, CRP are significantly higher and albumin, lymphocyte levels are significantly lower in nonsurvival group. D-dimer and procalcitonin levels are significantly higher in nonsurvival group. CCI score and neutrophil, creatinine, ALT, AST, d-dimer and procalcitonin elevations were correlated. Low albumin and lymphocyte levels were correlated with the CCI score. There was no significant correlation between ferritin, sedimentation, CRP levels and CCI score. A multivariate logistic regression analysis indicated that anaemia, elevated CRP (> 10-20 × upper limit), procalcitonin (> 5-10 × upper limit), ALT, AST levels and higher CCI score were independent risk factors for mortality in COVID-19 patients.

CONCLUSION

Anaemia, elevated CRP, procalcitonin levels, ALT, AST levels and higher CCI score were found independent risk factors for mortality in COVID-19 patients.

摘要

目的

已提出多种参数来预测冠状病毒病患者的预后。本研究的目的是评估年龄校正后的CCI评分和生化参数对预测COVID-19患者入院时预后的效用。

患者与方法

本研究共纳入511例患者。仅纳入拭子或血清学检测呈阳性的患者。比较了COVID-19存活和非存活住院患者的临床特征。比较了两组患者的血红蛋白、血小板、血沉、肌酐、谷草转氨酶(AST)、谷丙转氨酶(ALT)、乳酸脱氢酶(LDH)、肌酸激酶(CK)、白蛋白、铁蛋白、淋巴细胞、中性粒细胞、C反应蛋白(1 - 5;5 - 10;10 - 20×上限)、降钙素原(5 - 10;10 - 20;> 20×上限)、D - 二聚体(> 2×上限)、年龄、性别、慢性病和CCI评分。

结果

68例患者死亡,443例患者存活。存活组的平均年龄为74.3±7.3岁,非存活组为76.7±8.0岁。非存活组的年龄、男性、缺血性心脏病(CHD)、慢性肾病和活动性恶性肿瘤在统计学上更高。比较了存活组和非存活组的生化参数。非存活组的CCI评分、AST、LDH、CK、铁蛋白、C反应蛋白显著更高,白蛋白、淋巴细胞水平显著更低。非存活组的D - 二聚体和降钙素原水平显著更高。CCI评分与中性粒细胞、肌酐、ALT、AST、D - 二聚体和降钙素原升高相关。低白蛋白和淋巴细胞水平与CCI评分相关。铁蛋白、血沉、C反应蛋白水平与CCI评分之间无显著相关性。多因素逻辑回归分析表明,贫血、C反应蛋白升高(> 10 - 20×上限)、降钙素原升高(> 5 - 10×上限)、ALT、AST水平以及较高的CCI评分是COVID-19患者死亡的独立危险因素。

结论

贫血、C反应蛋白升高、降钙素原水平、ALT、AST水平以及较高的CCI评分是COVID-19患者死亡的独立危险因素。

相似文献

4
Routine laboratory parameters in estimating mortality and morbidity in COVID-19 diagnosed cases followed in the intensive care unit.
Eur Rev Med Pharmacol Sci. 2023 Jun;27(12):5885-5892. doi: 10.26355/eurrev_202306_32828.
6
Mortality Prediction of COVID-19 Patients at Intensive Care Unit Admission.
Cureus. 2021 Nov 18;13(11):e19690. doi: 10.7759/cureus.19690. eCollection 2021 Nov.
8
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.
9
Risk factors for infection and mortality among hemodialysis patients during COVID-19 pandemic.
Int Urol Nephrol. 2022 Mar;54(3):661-669. doi: 10.1007/s11255-021-02926-3. Epub 2021 Jul 5.
10
SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients.
Infect Drug Resist. 2024 Apr 29;17:1653-1667. doi: 10.2147/IDR.S463238. eCollection 2024.

引用本文的文献

2
Tracing In-Hospital COVID-19 Outcomes: A Multistate Model Exploration (TRACE).
Life (Basel). 2024 Sep 21;14(9):1195. doi: 10.3390/life14091195.
3
Comparative study of the severity of Covid-19 infection between female and male patients.
Niger Med J. 2024 Apr 21;65(1):56-66. doi: 10.60787/nmj-v65i1-451. eCollection 2024 Jan-Feb.
4
Serum butyrylcholinesterase as a marker of COVID-19 mortality: Results of the monocentric prospective observational study.
Chem Biol Interact. 2023 Aug 25;381:110557. doi: 10.1016/j.cbi.2023.110557. Epub 2023 May 19.
5
Cytokine Levels and Severity of Illness Scoring Systems to Predict Mortality in COVID-19 Infection.
Healthcare (Basel). 2023 Jan 29;11(3):387. doi: 10.3390/healthcare11030387.

本文引用的文献

1
Elevated Liver Enzymes along with Comorbidity Is a High Risk Factor for COVID-19 Mortality: A South Indian Study on 1,512 Patients.
J Clin Transl Hepatol. 2022 Feb 28;10(1):120-127. doi: 10.14218/JCTH.2020.00100. Epub 2021 Jun 16.
2
Age-adjusted Charlson Comorbidity Index: A Simple Tool, but Needs Further Validation in COVID-19 Patients.
Indian J Crit Care Med. 2021 Sep;25(9):963-964. doi: 10.5005/jp-journals-10071-23973.
4
Roles of certain biochemical and hematological parameters in predicting mortality and ICU admission in COVID-19 patients.
Rev Assoc Med Bras (1992). 2021 Jul 9;67Suppl 1(Suppl 1):67-73. doi: 10.1590/1806-9282.67.Suppl1.20200788. eCollection 2021.
5
Hematological profile and biochemical markers of COVID-19 non-survivors: A retrospective analysis.
Clin Epidemiol Glob Health. 2021 Jul-Sep;11:100770. doi: 10.1016/j.cegh.2021.100770. Epub 2021 May 8.
6
Risk factors for predicting mortality of COVID-19 patients: A systematic review and meta-analysis.
PLoS One. 2020 Nov 30;15(11):e0243124. doi: 10.1371/journal.pone.0243124. eCollection 2020.
7
Risk factors for severe and critically ill COVID-19 patients: A review.
Allergy. 2021 Feb;76(2):428-455. doi: 10.1111/all.14657. Epub 2020 Dec 4.
8
Predictors of COVID-19 severity: a systematic review and meta-analysis.
F1000Res. 2020 Sep 9;9:1107. doi: 10.12688/f1000research.26186.2. eCollection 2020.
9
Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis.
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2103-2109. doi: 10.1016/j.dsx.2020.10.022. Epub 2020 Oct 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验